Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy
Autor: | Buchholz, Thomas A, Huang, Eugene H, Berry, Donald, Pusztai, Lajos, Strom, Eric A, McNeese, Marsha D, Perkins, George H, Schechter, Naomi R, Kuerer, Henry M, Buzdar, Aman U, Valero, Vicente, Hunt, Kelly K, Hortobagyi, Gabriel N, Sahin, Aysegul A |
---|---|
Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 2004 59(5):1337-1342 |
Databáze: | ScienceDirect |
Externí odkaz: |